| Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes M Husain, AL Birkenfeld, M Donsmark, K Dungan, FG Eliaschewitz, ... New England Journal of Medicine 381 (9), 841-851, 2019 | 1531 | 2019 |
| Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications HJL Heerspink, BA Perkins, DH Fitchett, M Husain, DZI Cherney Circulation 134 (10), 752-772, 2016 | 1288 | 2016 |
| Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor–dependent and–independent pathways K Ban, MH Noyan-Ashraf, J Hoefer, SS Bolz, DJ Drucker, M Husain Circulation 117 (18), 2340-2350, 2008 | 1246 | 2008 |
| Local proliferation dominates lesional macrophage accumulation in atherosclerosis CS Robbins, I Hilgendorf, GF Weber, I Theurl, Y Iwamoto, JL Figueiredo, ... Nature medicine 19 (9), 1166-1172, 2013 | 1164 | 2013 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1100 | 2021 |
| GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice MH Noyan-Ashraf, MA Momen, K Ban, AM Sadi, YQ Zhou, AM Riazi, ... Diabetes 58 (4), 975-983, 2009 | 700 | 2009 |
| Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction SA Dick, JA Macklin, S Nejat, A Momen, X Clemente-Casares, ... Nature immunology 20 (1), 29-39, 2019 | 682 | 2019 |
| Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories CL Bauwens, R Peerani, S Niebruegge, KA Woodhouse, E Kumacheva, ... Stem cells 26 (9), 2300-2310, 2008 | 559 | 2008 |
| Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE-HF trial ME Nassif, SL Windsor, F Tang, Y Khariton, M Husain, SE Inzucchi, ... Circulation 140 (18), 1463-1476, 2019 | 415 | 2019 |
| Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death IN Mungrue, R Gros, X You, A Pirani, A Azad, T Csont, R Schulz, J Butany, ... The Journal of clinical investigation 109 (6), 735-743, 2002 | 414 | 2002 |
| Self-renewing resident arterial macrophages arise from embryonic CX3CR1+ precursors and circulating monocytes immediately after birth S Ensan, A Li, R Besla, N Degousee, J Cosme, M Roufaiel, EA Shikatani, ... Nature immunology 17 (2), 159-168, 2016 | 378 | 2016 |
| A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia M Toporsian, R Gros, MG Kabir, S Vera, K Govindaraju, DH Eidelman, ... Circulation research 96 (6), 684-692, 2005 | 336 | 2005 |
| Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice M Sauvé, K Ban, MA Momen, YQ Zhou, RM Henkelman, M Husain, ... Diabetes 59 (4), 1063-1073, 2010 | 304 | 2010 |
| The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient DL Costantini, EP Arruda, P Agarwal, KH Kim, Y Zhu, W Zhu, M Lebel, ... Cell 123 (2), 347-358, 2005 | 298 | 2005 |
| Autologous porcine heart cell transplantation improved heart function after a myocardial infarction RK Li, RD Weisel, DAG Mickle, ZQ Jia, EJ Kim, T Sakai, S Tomita, ... The Journal of thoracic and cardiovascular surgery 119 (1), 62-68, 2000 | 291 | 2000 |
| Cardiac function in mice lacking the glucagon-like peptide-1 receptor R Gros, X You, LL Baggio, MG Kabir, AM Sadi, IN Mungrue, TG Parker, ... Endocrinology 144 (6), 2242-2252, 2003 | 283 | 2003 |
| Generation of human embryonic stem cell‐derived mesoderm and cardiac cells using size‐specified aggregates in an oxygen‐controlled bioreactor S Niebruegge, CL Bauwens, R Peerani, N Thavandiran, S Masse, ... Biotechnology and bioengineering 102 (2), 493-507, 2009 | 279 | 2009 |
| A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity MH Noyan-Ashraf, EA Shikatani, I Schuiki, I Mukovozov, J Wu, RK Li, ... Circulation 127 (1), 74-85, 2013 | 269 | 2013 |
| Glucagon-like peptide (GLP)-1 (9-36) amide-mediated cytoprotection is blocked by exendin (9-39) yet does not require the known GLP-1 receptor K Ban, KH Kim, CK Cho, M Sauve, EP Diamandis, PH Backx, DJ Drucker, ... Endocrinology 151 (4), 1520-1531, 2010 | 268 | 2010 |
| Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice LL Yang, R Gros, MG Kabir, A Sadi, AI Gotlieb, M Husain, DJ Stewart Circulation 109 (2), 255-261, 2004 | 229 | 2004 |
Eric A ShikataniNovartis Institutes for Biomedical ResearchVerified email at novartis.com
